대한핵의학회지 (1967년~2009년)
대한핵의학회지 2001;35(1)75~6
원저 / Tc-99m Infecton과 Ciprofloxacin의 생체외 항균력 비교 ( Comparison of in vitro Antimicrobial Activities of Tc-99m Infecton and Ciprofloxacin )
()
Author 김성민(Sung Min Kim),범희승(Hee Seung Bom),송호천(Ho Chun Song),정환정(Hwan Jeong Jeong),김지열(Ji Yeul Kim),신종희(Jong Hee Shin),
Affiliation
Abstract

Purpose: There was little evidence that Tc-99m labeled ciprofloxacin (Infecton) located inside of bacteria. Antimicrobial activity of Infecton could be an indirect evidence of its location. We compared in vitro antimicrobial activities of Infecton and ciprofloxacin. Materials and methods: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of Infecton and ciprofloxacin against three standard strains of bacteria, Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were measured using modified broth macrodilution techniques and pour plate methods, respectively. Data were expressed as mean±SE (range). Results: MICs of Infecton and ciprofloxacin were 1.12±0.20 (0.8∼1.6) ㎍/㎖ and 0.36±0.04 (0.2∼0.4) ㎍/㎖ for S. aureus, 0.03±0.005 (0.025∼0.05) ㎍/㎖ and 0.011±0.001 (0.006∼0.012) ㎍/㎖ for E. coli, and 0.96±0.16 (0.8∼1.6) ㎍/㎖ and 0.56±0.098 (0.4∼0.8) ㎍/㎖ for P. aeruginosa, respectively. MBCs of Infecton and ciprofloxacin were 2.56±0.39 (1.6∼3.2) ㎍/㎖ and 0.88±0.2 (0.4∼1.6) ㎍/㎖ for S. aureus, 0.04±0.06 (0.025∼0.05) ㎍/㎖ and 0.02±0.01 (0.025∼0.05) ㎍/㎖ for E. coli, and 2.24±0.39 (1.6∼3.2) ㎍/㎖ and 1.44±0.16 (0.8∼1.6) ㎍/㎖ for P. aeruginosa, respectively. Conclusion: Although both MICs and MBCs of Infecton were higher than those of ciprofloxacin, all three standard bacterial strains were sensitive to Infecton. It could be an indirect evidence that Tc-99m Infecton be a specific imaging agent for bacterial infection. (Korean J Nucl Med 2001;35:75-80)

Keyword Key Words: Tc-99m Infecton, Ciprofloxacin, Antimicrobial activity, Infection
Full text Article 28503311.pdf 28503311.pdf
(03121)서울시 종로구 지봉로 29 금호팔레스빌딩 1705호
TEL : 02-745-2040 FAX : 02-745-3833 E-mail : ksnm@ksnm.or.kr
Copyright 2012 by The Korean Society of Nuclear Medicine(KSNM)